Study on the Creative Issues of the Invention of Chinese Medicine Compositions
-
摘要: 针对中药组合物发明的创造性判断问题以及中药组合物发明的创造性与中药药理之间的关系问题展开研究。如果中药组合物发明是中医药领域的技术人员在现有的中药处方的基础上, 仅仅根据已知的中药药理进行合乎逻辑的分析、推理或者有限的试验就可以得到, 且没有产生预料不到的技术效果, 则该中药组合物发明不具备创造性; 如果中药组合物的原料组成或者技术效果是不容易想到的, 则该中药组合物发明具备创造性。在中药组合物发明的创造性与中药药理的关系问题上, 具备创造性的发明必然符合中药药理, 但符合中药药理的发明不一定具备创造性, 而人们对中药药理的认识也是不断拓展和深化的。Abstract: A study was conducted on the issue about estimating the creativity of inventions of Chinese medicine compositions and the relationship between the creativity of inventions of Chinese medicine compositions and the pharmacology of Chinese medicine. It is argued that if the invention of Chinese medicine composition can be obtained by technicians in the related field only according to the existing prescriptions by logical analysis, reasoning or limited experiments based on the known pharmacology of Chinese medicine without any unexpected technical effect, then the invention of the Chinese medicine composition is not creative. However, if the raw materials or technical effect of the Chinese medicine composition is not easy to think of, the invention of the Chinese medicine composition is creative. On the relationship between creativity and pharmacology of Chinese medicine, creative inventions must be in line with the pharmacology of Chinese medicine, but inventions conform to the pharmacology of Chinese medicine are not necessarily creative. Besides, people's understanding of the pharmacology of Chinese medicine is constantly expanding and deepening.
-
[1] 张欢. 预料不到的技术效果与技术领域之间的关系分析[J]. 科技创新与应用, 2020(16): 141-142. https://www.cnki.com.cn/Article/CJFDTOTAL-CXYY202016059.htm [2] 李伟, 李哲. 浅议省略发明中"依然保持原有的全部功能"的创造性判断[C]//中华全国专利代理人协会. 2013年中华全国专利代理人协会年会暨第四届知识产权论坛论文汇编第二部分. 2013: 4. [3] 沈婷婷, 周循. 发明专利创造性的判断[J]. 中国高新科技, 2021(1): 60-61. https://www.cnki.com.cn/Article/CJFDTOTAL-GXKE202101027.htm [4] 一种养生保健中药[P]. 中华人民共和国国家知识产权局, CN106138942A. [5] 一种养生保健酒及其制备方法[P]. 中华人民共和国国家知识产权局, CN105273940A. [6] 中国及多国专利审查信息查询[EB/OL]. [2021-09-11]. http://cpquery.cnipa.gov.cn/. [7] 徐丹. 从授权和确权两个视角解读制药用途权利要求[J]. 中国发明与专利. 2019, 16(3): 116-120. https://www.cnki.com.cn/Article/CJFDTOTAL-FMYZ201903023.htm [8] 彭晓琦. 我国专利制度对于医药用途发明的专利保护模式[J]. 中国医药工业杂志, 2017, 48(4): 614-619. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHOU201704033.htm [9] 风湿祛痛中药组合物在制备抗血管新生药物中的用途[P]. 中华人民共和国国家知识产权局, CN109395015B. -
点击查看大图
计量
- 文章访问数: 408
- HTML全文浏览量: 208
- PDF下载量: 18
- 被引次数: 0
下载:
